HEPATITIS D
Clinical trials for HEPATITIS D explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS D trials appear
Sign up with your email to follow new studies for HEPATITIS D, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hepatitis d: drug trial targets virus and liver health
Disease control OngoingThis study tests a new drug called hepalatide in 90 adults with chronic hepatitis D, a serious liver infection. Participants receive either a low or high dose of the drug for 48 weeks, or wait for treatment. The goal is to see if the drug can lower the virus level and improve liv…
Matched conditions: HEPATITIS D
Phase: PHASE2 • Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 05:35 UTC
-
Hepatitis d drug may ease liver pressure in cirrhosis patients
Disease control OngoingThis study looks at whether the antiviral drug Bulevirtide can reduce high blood pressure in the liver (portal hypertension) in people with hepatitis B and D who also have liver cirrhosis. High liver pressure can lead to serious problems like bleeding. The study will measure live…
Matched conditions: HEPATITIS D
Sponsor: Hannover Medical School • Aim: Disease control
Last updated May 26, 2026 05:34 UTC